Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies

Acta Neuropathologica

Volumn 113, Issue 1, 2007, Pages 63-73

  Lagalwar, Sarita ^a   Berry, Robert W ^a   Binder, Lester I ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; GVDs; NFTs; SAPK JNK; Tau protein; Tauopathies

Indexed keywords

STRESS ACTIVATED PROTEIN KINASE; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; CYTOPLASM; DEGENERATIVE DISEASE; DISEASE MARKER; FEMALE; GRANULE CELL; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR MECHANICS; NEUROPATHOLOGY; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; TAUOPATHY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CYTOPLASMIC GRANULES; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; NEURODEGENERATIVE DISEASES; NEURONS; PHOSPHORYLATION; PICK DISEASE OF THE BRAIN; SUPRANUCLEAR PALSY, PROGRESSIVE; TAUOPATHIES; VACUOLES;

EID: 33751256001     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-006-0159-4     Document Type: Article

References (58)

1. Arendt T (2004) Neurodegeneration and plasticity. Int J Dev Neurosci 22:507-514
2. Ball MJ (1977) Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study. Acta Neuropathol (Berl) 37:111-118
3. Bence NF, Sampat RM, Kopito RR (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292:1552-1555
4. Bennett EJ, Bence NF, Jayakumar R, Kopito RR (2005) Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol Cell 17:351-365
5. Berry RW, Quinn B, Johnson N, Cochran EJ, Ghoshal N, Binder LI (2001) Pathological glial tau accumulations in neurodegenerative disease: review and case report. Neurochem Int 39:469-479
6. Berry RW, Sweet AP, Clark FA, Lagalwar S, Lapin BR, Wang T, Topgi S, Guillozet-Bongaarts AL, Cochran EJ, Bigio EH, Binder LI (2004) Tau epitope display in progressive supranuclear palsy and corticobasal degeneration. J Neurocytol 33:287-295
7. Bondareff W, Wischik CM, Novak M, Roth M (1991) Sequestration of tau by granulovacuolar degeneration in alzheimer's disease. Am J Pathol 139:641-647
8. Braak H, Braak E (1995) Staging of alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 16: 271-278; discussion 278-284
9. Carmel G, Mager EM, Binder LI, Kuret J (1996) The structural basis of monoclonal antibody alz50's selectivity for alzheimer's disease pathology. J Biol Chem 271:32789-32795
10. Del Villar K, Miller CA (2004) Down-regulation of denn/madd, a tnf receptor binding protein, correlates with neuronal cell death in alzheimer's disease brain and hippocampal neurons. Proc Natl Acad Sci USA 101:4210-4215
11. Dickson DW, Ksiezak-Reding H, Davies P, Yen SH (1987) A monoclonal antibody that recognizes a phosphorylated epitope in alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration. Acta Neuropathol (Berl) 73:254-258
12. Drexler HC (1997) Activation of the cell death program by inhibition of proteasome function. Proc Natl Acad Sci USA 94:855-860
13. Feany MB, Mattiace LA, Dickson DW (1996) Neuropathologic overlap of progressive supranuclear palsy, pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol 55:53-67
14. Flood F, Murphy S, Cowburn RF, Lannfelt L, Walker B, Johnston JA (2005) Proteasome-mediated effects on amyloid precursor protein processing at the gamma-secretase site. Biochem J 385:545-550
15. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL (2003) Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in alzheimer's disease. Proc Natl Acad Sci USA 100:10032-10037
16. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, LeBlanc A, Smith D, Rigby M, Shearman MS, Clarke EE, Zheng H, Van Der Ploeg LH, Ruffolo SC, Thornberry NA, Xanthoudakis S, Zamboni RJ, Roy S, Nicholson DW (1999) Involvement of caspases in proteolytic cleavage of alzheimer's amyloid-beta precursor protein and amyloidogenic a beta peptide formation. Cell 97:395-406
17. Ghanevati M, Miller CA (2005) Phospho-beta-catenin accumulation in alzheimer's disease and in aggresomes attributable to proteasome dysfunction. J Mol Neurosci 25:79-94
18. Ghoshal N, Smiley JF, DeMaggio AJ, Hoekstra MF, Cochran EJ, Binder LI, Kuret J (1999) A new molecular link between the fibrillar and granulovacuolar lesions of alzheimer's disease. Am J Pathol 155:1163-1172
19. Ghoshal N, Garcia-Sierra F, Wuu J, Leurgans S, Bennett DA, Berry RW, Binder LI (2002) Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and alzheimer's disease. Exp Neurol 177:475-493
20. Ghribi O, Prammonjago P, Herman MM, Spaulding NK, Savory J (2003) Abeta(1-42)-induced jnk and erk activation in rabbit hippocampus is differentially regulated by lithium but is not involved in the phosphorylation of tau. Brain Res Mol Brain Res 119:201-206
21. Greenberg SG, Davies P, Schein JD, Binder LI (1992) Hydrofluoric acid-treated tau phf proteins display the same biochemical properties as normal tau. J Biol Chem 267:564-569
22. Herndon RM (1964) Lamellar bodies, an unusual arrangement of the granular endoplasmic reticulum. J Cell Biol 20:338-342
23. Hideshima T, Mitsiades C, Akiyama M, Hayashi T, Chauhan D, Richardson P, Schlossman R, Podar K, Munshi NC, Mitsiades N, Anderson KC (2003) Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor ps-341. Blood 101:1530-1534
24. Holzer M, Gartner U, Stobe A, Hartig W, Gruschka H, Bruckner MK, Arendt T (2002) Inverse association of pin1 and tau accumulation in alzheimer's disease hippocampus. Acta Neuropathol (Berl) 104:471-481
25. Ikegami K, Kimura T, Katsuragi S, Ono T, Yamamoto H, Miyamoto E, Miyakawa T (1996) Immunohistochemical examination of phosphorylated tau in granulovacuolar degeneration granules. Psychiatry Clin Neurosci 50:137-140
26. Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, Lewis J, Hutton M, Dickson DW, Yen SH (2003) Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. Am J Pathol 163:1057-1067
27. Jellinger KA, Stadelmann C (2000) Mechanisms of cell death in neurodegenerative disorders. J Neural Transm Suppl 59:95-114
28. Kannanayakal TJ, Tao H, Vandre DD, Kuret J (2006) Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions. Acta Neuropathol (Berl) 111:413-421
29. Kefas BA, Cai Y, Ling Z, Heimberg H, Hue L, Pipeleers D, Van de Casteele M (2003) Amp-activated protein kinase can induce apoptosis of insulin-producing min6 cells through stimulation of c-jun-n-terminal kinase. J Mol Endocrinol 30:151-161
30. Keller JN, Hanni KB, Markesbery WR (2000) Impaired proteasome function in lzheimer's disease. J Neurochem 75:436-439
31. King ME, Ghoshal N, Wall JS, Binder LI, Ksiezak-Reding H (2001) Structural analysis of pick's disease-derived and in vitro-assembled tau filaments. Am J Pathol 158:1481-1490
32. Komori T (1999) Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and pick's disease. Brain Pathol 9:663-679
33. Kuret J, Johnson GS, Cha D, Christenson ER, DeMaggio AJ, Hoekstra MF (1997) Casein kinase 1 is tightly associated with paired-helical filaments isolated from alzheimer's disease brain. J Neurochem 69:2506-2515
34. Lagalwar S, Guillozet-Bongaarts AL, Berry RW, Binder LI (2006) Formation of phospho-sapk/jnk granules in the hippocampus is an early event in alzheimer's disease. J Neuropathol Exp Neurol 65:455-464
35. Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP (2002) The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in alzheimer's disease. Acta Neuropathol (Berl) 103:91-99
36. Love S, Saitoh T, Quijada S, Cole GM, Terry RD (1988) Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, pick bodies and lewy bodies. J Neuropathol Exp Neurol 47:393-405
37. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in alzheimer disease and down syndrome. Proc Natl Acad Sci USA 82:4245-4249
38. Maundrell K, Antonsson B, Magnenat E, Camps M, Muda M, Chabert C, Gillieron C, Boschert U, Vial-Knecht E, Martinou JC, Arkinstall S (1997) Bcl-2 undergoes phosphorylation by c-jun n-terminal kinase/ stress-activated protein kinases in the presence of the constitutively active gtp-binding protein rac1. J Biol Chem 272:25238-25242
39. Mena R, Robitaille Y, Cuello AC (1992) New patterns of intraneuronal accumulation of the microtubular binding domain of tau in granulovacuolar degeneration. J Geriatr Psychiatry Neurol 5:132-141
40. Mesulam MM (1999) Neuroplasticity failure in alzheimer's disease: Bridging the gap between plaques and tangles. Neuron 24:521-529
41. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for alzheimer's disease (cerad). Part ii. Standardization of the neuropathologic assessment of alzheimer's disease. Neurology 41:479-486
42. Morroni M, Barbatelli G (2001) Stages of development of the ribosome-lamella complex: An ultrastructural study. Ultrastruct Pathol 25:335-343
43. Okamoto K, Hirai S, Iizuka T, Yanagisawa T, Watanabe M (1991) Reexamination of granulovacuolar degeneration. Acta Neuropathol (Berl) 82:340-345
44. Pasquini LA, Besio Moreno M, Adamo AM, Pasquini JM, Soto EF (2000) Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells. J Neurosci Res 59:601-611
45. Probst A, Herzig MC, Mistl C, Ipsen S, Tolnay M (2001) Perisomatic granules (non-plaque dystrophic dendrites) of hippocampal ca1 neurons in alzheimer's disease and pick's disease: A lesion distinct from granulovacuolar degeneration. Acta Neuropathol (Berl) 102:636-644
46. Qiu JH, Asai A, Chi S, Saito N, Hamada H, Kirino T (2000) Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J Neurosci 20:259-265
47. Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH (2000) Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: Differences in vitro between the mitogen-activated protein kinases erk2, c-jun n-terminal kinase and p38, and glycogen synthase kinase-3beta. J Neurochem 74:1587-1595
48. Rogatsky I, Logan SK, Garabedian MJ (1998) Antagonism of glucocorticoid receptor transcriptional activation by the c-jun n-terminal kinase. Proc Natl Acad Sci USA 95:2050-2055
49. Schwab C, DeMaggio AJ, Ghoshal N, Binder LI, Kuret J, McGeer PL (2000) Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. Neurobiol Aging 21:503-510
50. Selznick LA, Holtzman DM, Han BH, Gokden M, Srinivasan AN, Johnson EM Jr., Roth KA (1999) In situ immunodetection of neuronal caspase-3 activation in alzheimer disease. J Neuropathol Exp Neurol 58:1020-1026
51. Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Bruck W, Jellinger K, Lassmann H (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol 155:1459-1466
52. Su JH, Kesslak JP, Head E, Cotman CW (2002) Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in alzheimer's disease and down's syndrome brain. Acta Neuropathol (Berl) 104:1-6
53. Tomlinson BE, Kitchener D (1972) Granulovacuolar degeneration of hippocampal pyramidal cells. J Pathol 106:165-185
54. Trojanowski JQ, Schmidt ML, Shin RW, Bramblett GT, Rao D, Lee VM (1993) Altered tau and neurofilament proteins in neuro-degenerative diseases: Diagnostic implications for alzheimer's disease and lewy body dementias. Brain Pathol 3:45-54
55. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D (2000) Coupling of stress in the er to activation of jnk protein kinases by transmembrane protein kinase ire1. Science 287:664-666
56. Xu M, Shibayama H, Kobayashi H, Yamada K, Ishihara R, Zhao P, Takeuchi T, Yoshida K, Inagaki T, Nokura K (1992) Granulovacuolar degeneration in the hippocampal cortex of aging and demented patients' a quantitative study. Acta Neuropathol (Berl) 85:1-9
57. Yoshida H, Hastie CJ, McLauchlan H, Cohen P, Goedert M (2004) Phosphorylation of microtubule-associated protein tau by isoforms of c-jun n-terminal kinase (jnk). J Neurochem 90:352-358
58. Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, Smith MA (2001) Activation and redistribution of c-jun n-terminal kinase/stress activated protein kinase in degenerating neurons in alzheimer's disease. J Neurochem 76:435-441